Damnacanthal-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁(yè)
Damnacanthal-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁(yè)
Damnacanthal-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEDamnacanthalCat. No.: HY-108485CAS No.: 477-84-9分式: CHO分量: 282.25作靶點(diǎn): Src; Apoptosis; Fungal作通路: Protein Tyrosine Kinase/RTK; Apoptosis; Anti-infection儲(chǔ)存式: 4C, protect from light* In solvent : -80C, 6 months; -20C, 1 month (prot

2、ect fromlight)BIOLOGICAL ACTIVITY物活性 Damnacanthal從 Morinda citrifolia 的根中分離出來(lái)的蒽醌。Damnacanthal種強(qiáng)效選擇性的 p56lck酪氨酸激酶活性的抑制劑。天然的 Damnacanthal 抑制 p56lck 的磷酸化和外底物的磷酸化,IC50 分別為46 nM 和 220 nM。Damnacanthal種具有抗癌活性的有效凋亡誘導(dǎo)劑。Damnacanthal 在中也具有鎮(zhèn)痛,抗炎作,并且對(duì)念珠具有抗真活性。IC50 & Target IC50: 46 nM (p56 lck autophosphorylatio

3、n) and 220 nM (phosphorylation of exogenous substrates by p56lck) 1;Apoptosis 2;Candida albicans 2體外研究Damnacanthal has 100-fold selectivity for p56lck over the serine/threonine kinases, protein kinase A andprotein kinase C, and 40-fold selectivity for p56lck over four receptor tyrosine kinases. Damn

4、acanthal alsodemonstrates modest (7-20-fold), but highly statistically significant, selectivity for p56lck over the homologousenzymes p60src and p59fyn 1.Damnacanthal (0.1-100 M; 1-4 days; HCT-116 and SW480 cells) treatment results in a significant reductionof cell proliferation in a concentration-

5、and time-dependent manner 2.Damnacanthal (1-50 M; 72 hours; HCT-116 cells) treatment results in a significant enrichment in thenumber of cells in the S/G1 and G2/G1 phases at concentration of 50 M 2.Damnacanthal (10 M; 24 hours; HCT-116 cells) treatment significantly increases caspase 3/7 activity.D

6、amnacanthal-induced apoptosis 2.Damnacanthal (0.1-10 M; 24 hours; HCT-116 cells) treatment induces NAG-1 expression in HCT-116 cells.Cyclin D1 expression is reduced at 10 M of Damnacanthal, whereas p21 and p53 does not alter their1/3 Master of Small Molecules 您邊的抑制劑師www.MedChemEexpression. PARP clea

7、vage is seen at 10 M Damnacanthal treatment only in HCT-116 cells, where NAG-1is induced 2.Damnacanthal treatment for 2 weeks shows significant decreasing colony number in HCT-116 cells in aconcentration-dependent manner. Damnacanthal-treated cells show a dramatic inhibition of clonogeniccapacity. D

8、amnacanthal-treated (1-50 M; 48 hours) cells significantly inhibits the migration of HCT-116 cellsin a concentration-dependent manner 2.Cell Proliferation Assay 2Cell Line: HCT-116 and SW480 cellsConcentration: 0.1 M, 1 M, 10 M, 100 MIncubation Time: 1, 2, and 4 daysResult: Resulted in a significant

9、 reduction of cell proliferation in a concentration- and time-dependent manner.Cell Cycle Analysis 2Cell Line: HCT-116 cellsConcentration: 1 M, 10 M and 50 MIncubation Time: 72 hoursResult: Resulted in a significant enrichment in the number of cells in the S/G1 and G2/G1phases at concentration of 50

10、 M.Apoptosis Analysis 2Cell Line: HCT-116 cellsConcentration: 10 MIncubation Time: 24 hoursResult: Significantly increased caspase 3/7 activity.Western Blot Analysis 2Cell Line: HCT-116 cellsConcentration: 0.1 M, 1 M and 10 MIncubation Time: 24 hoursResult: NAG-1 was induced in HCT-116 cells in a do

11、se- and time-dependent manner. Cyclin D1expression was reduced at 10 M.2/3 Master of Small Molecules 您邊的抑制劑師www.MedChemE體內(nèi)研究 Damnacanthal (10-100 mg/kg; oral administration; for 10-300 minutes; male ddY mice) treatment exhibits asignificant antinociceptive effect in a dose-dependent manner in the fo

12、rmalin test. Administration ofdamnacanthal (100 mg/kg) shows significant inhibition of histamine-induced paw edema 4.Animal Model: Male ddY mice (5-6 weeks) injected with formalin or Histamine 4Dosage: 10 mg/kg, 30 mg/kg and 100 mg/kgAdministration: Oral administration; for 10 minutes, 30 minutes, 6

13、0 minutes or 300 minutesResult: Significantly reduced the growth of human lung tumor without acute toxicity.REFERENCES1. Faltynek CR, et al. Damnacanthal is a highly potent, selective inhibitor of p56lck tyrosine kinase activity. Biochemistry. 1995 Sep26;34(38):12404-10.2. Nualsanit T, et al. Damnac

14、anthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells. J Nutr Biochem.2012 Aug;23(8):915-23.3. Aziz MY, et al. Damnacanthal is a potent inducer of apoptosis with anticancer activity by stimulating p53 and p21 genes in MCF-7 breastcancer cells. Oncol Lett. 2014 May;7(5):1479-1484.4. Okusada K, et al. The antinociceptive and anti-inflammatory action of the CHCl3-soluble phase and its main active component,damnacanthal, isolated from the root of Morinda citrifolia. Biol Pharm Bul

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論